# Resolution of long standing hypergammaglobulinemic purpura of Waldenström after initiating treatment for cystic fibrosis with Elexacaftor–Tezacaftor–Ivacaftor

**Authors:** Kimberly Tantuco, Jennifer Beecker, Melanie Chin

PMC · DOI: 10.1016/j.jdcr.2023.09.037 · 2023-10-15

## Full-text entities

- **Genes:** CFTR (CF transmembrane conductance regulator) [NCBI Gene 1080] {aka ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR}, LOC102723407 (immunoglobulin heavy variable 4-38-2-like) [NCBI Gene 102723407] {aka IGHV4, IGHV4-30, IGHV4-38-2, IGHV4-39, IGHV4-b, IGVH4-39}
- **Diseases:** lung disease (MESH:D008171), macules (MESH:C537836), cough (MESH:D003371), hyperpigmentation (MESH:D017495), inflammation (MESH:D007249), hepatitis C (MESH:D019698), infections (MESH:D007239), pain (MESH:D010146), arthritis (MESH:D001168), Purpura (MESH:D011693), Sjogren's antibodies (MESH:D012859), clubbing (MESH:D003025), purpuric rash (MESH:D005076), autoimmune hepatitis (MESH:D019693), edema of the feet (MESH:D004487), Purpuric macules (MESH:C537186), sputum production (MESH:D007787), systemic lupus erythematosus (MESH:D008180), Flares (MESH:D000067251), CF (MESH:D003550), polyclonal gammopathy (MESH:C564707), arthralgia (MESH:D018771), died (MESH:D003643), HGPW (MESH:D011694), multiple myeloma (MESH:D009101), lung infections (MESH:D012141), reduced daily pulmonary symptoms (MESH:D001523), shortness of breath (MESH:D004417), multisystem disorder (MESH:D019578)
- **Chemicals:** mycophenolate mofetil (MESH:D009173), indomethacin (MESH:D007213), rituximab (MESH:D000069283), Hydroxychloroquine (MESH:D006886), aspirin (MESH:D001241), ETI (-), colchicine (MESH:D003078), dapsone (MESH:D003622), alcohol (MESH:D000438)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** F508del

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10820255/full.md

---
Source: https://tomesphere.com/paper/PMC10820255